Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update.
Shanghai Pharmaceuticals Holding Co., Ltd. successfully conducted its 2023 Annual General Meeting (AGM), with key outcomes including the approval of the Annual Report for 2023 and the Report of the Board of Directors for the same year. The AGM saw a healthy shareholder turnout, with over 62% of total shares carrying voting rights represented, and nearly unanimous support for the resolutions proposed. Additionally, the meeting included the appointment of a non-executive director and a new member to the Strategy Committee.
For further insights into HK:2607 stock, check out TipRanks’ Stock Analysis page.
